NeuroFlow this week announced that it has acquired the proprietary behavioral health analytics model developed at Salt Lake City-based Intermountain Health.

WHY IT MATTERS
The deal, which will see the clinically validated model integrated into NeuroFlow's platform, enhances the company's analytics and AI capabilities and enables broader deployment of powerful risk assessment models, according to the firm.

The predictive complexity algorithm – first developed in-house at Intermountain, and developed and refined over the past decade – identifies relationships among combined data variables, to guide targeted-risk decision-making and team treatment options and provide feedback about the effectiveness of ongoing interventions, while supporting tracking and assessment of changes in patients' conditions.

"In primary care, there are many interdependent factors to consider when identifying mental and physical health, and social care needs," said Tammer Attallah, LCSW, behavioral health clinical program executive director at Intermountain Health, in a statement.

"The creation of our standardized workflow assesses the complexity of these variables and offers shared decision support that identifies targeted, evidence-based physical, mental health, and social resources," Attallah explained.

The model uses data available from sources including patient self-reporting, disease registries, electronic health records and claims – using that information not just to stratify, but to provide a more contextualized and effective integrated course of higher-quality care.

NeuroFlow notes that patients are often overburdened with too many screening and assessment tools, and providers are challenged with integrating disparate data points – hindering patient-provider engagement and potential opportunities for shared decision-making. The Intermountain-developed model can help streamline behavioral healthcare processes with more reliable and relevant data.

WHY IT MATTERS
Intermountain has been a longtime leader in artificial intelligence and analytics innovations, such as AI-powered research aimed at improving high-acuity care, genAI to help ease clinician burden and a center to guide ethical deployments.

NeuroFlow's newest deal with the health system extends from a strategic collaboration announced this past summer, and the two organizations say they'll continue to collaborate on innovating the risk complexity model.

NeuroFlow – which acquired behavioral health assessment and measurement-based care company Owl in 2024 – says it plans to make the model's enhanced capabilities available to other clients later this year, and offer health systems behavioral health-intelligence tools to help improve provider decision-making and patient outcomes.

ON THE RECORD
"Intermountain's proven clinical workflow model is provided through high-functioning teams, an integrated mental and physical treatment plan, and the associated combination of targeted team resources," said Dr. Brenda Reiss-Brennan, mental health integration implementation science senior advisor at Intermountain Health, in a statement. "This provides highly effective and efficient pathways to positive outcomes."

Mike Miliard is executive editor of Healthcare IT News
Email the writer: mike.miliard@himssmedia.com
Healthcare IT News is a HIMSS publication.